Journal of Psychopharmacology

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Register here to gain access to SAGE's 500+ Journals Online

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bailey, J. E.
Right arrow Articles by Nutt, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bailey, J. E.
Right arrow Articles by Nutt, D. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Psychopharmacology, Vol. 17, No. 3, 252-259 (2003)
DOI: 10.1177/02698811030173002

Does the Brain Noradrenaline Network Mediate the Effects of the CO2 Challenge?

J. E. Bailey

Psychopharmacology Unit, Medical School, University of Bristol, Bristol, UK

S. V. Argyropoulos

Psychopharmacology Unit, Medical School, University of Bristol, Bristol, UK

S. L. Lightman

University Research Centre for Neuroendocrinology, Medical School, University of Bristol, Bristol, UK

D. J. Nutt

Psychopharmacology Unit, Medical School, University of Bristol, Bristol, UK, david.j.nutt{at}bristol.ac.uk

The inhalation of carbon dioxide (CO2) is commonly used in patients and volunteers as a means of producing anxiety or panic. It is generally believed that patients with panic disorder are more vulnerable to the effects of CO2 than patients with other anxiety disorders or healthy volunteers and there is speculation and debate as to the mechanism for this apparent sensitivity. Recent work from our group has shown that a single inhalation of 35% CO2 activates the hypothalamic-pituitary-adrenocortical (HPA) axis, increases blood pressure (BP) and increases subjective fear responses in healthy volunteers. Correlation analyses reveal a relationship between the changes in BP and the cortisol increase. These findings led us to postulate that a common mechanism may mediate these and the subjective responses to inhalation of CO2. We propose that the noradrenergic system, particularly the locus coeruleus (LC), but including the A1 and A2 cell groups, may be a key mediator of these responses. This article examines the evidence and discusses the results of studies from our laboratory in relation to a neuroanatomical model centring on the LC.

Key Words: anxiety • blood pressure • carbon dioxide • cortisol • locus coeruleus • noradrenaline (norepinephrine)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Br. J. PsychiatryHome page
J. R. Nash, P. A. Sargent, E. A. Rabiner, S. D. Hood, S. V. Argyropoulos, J. P. Potokar, P. M. Grasby, and D. J. Nutt
Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study
The British Journal of Psychiatry, September 1, 2008; 193(3): 229 - 234.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
S. Kasparov and A. G. Teschemacher
Altered central catecholaminergic transmission and cardiovascular disease
Exp Physiol, June 1, 2008; 93(6): 725 - 740.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
S. Z. Poma, S. Milleri, L. Squassante, G. Nucci, M. Bani, G. I. Perini, and E. Merlo-Pich
Characterization of a 7% carbon dioxide (CO2) inhalation paradigm to evoke anxiety symptoms in healthy subjects
J Psychopharmacol, September 1, 2005; 19(5): 494 - 503.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
M. Fendt, S. Siegl, and B. Steiniger-Brach
Noradrenaline Transmission within the Ventral Bed Nucleus of the Stria Terminalis Is Critical for Fear Behavior Induced by Trimethylthiazoline, a Component of Fox Odor
J. Neurosci., June 22, 2005; 25(25): 5998 - 6004.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
J. E. Bailey
The Application of Good Clinical Practice to Challenge Tests
J Psychopharmacol, March 1, 2004; 18(1): 16 - 16.
[PDF]


Home page
J PsychopharmacolHome page
E. Griez and K. Schruers
Mechanisms of CO2 Challenges
J Psychopharmacol, September 1, 2003; 17(3): 260 - 262.
[PDF]


Home page
J PsychopharmacolHome page
L. Bellodi, D. Caldirola, and A. Bertani
Does the Brain Noradrenaline Network Mediate the Effects of the CO2 Challenge?
J Psychopharmacol, September 1, 2003; 17(3): 263 - 264.
[PDF]


Home page
J PsychopharmacolHome page
J. M. Gorman
Does the Brain Noradrenaline Network Mediate the Effects of the CO2 Challenge?
J Psychopharmacol, September 1, 2003; 17(3): 265 - 266.
[PDF]